The Estée Lauder Companies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EL research report →
Range $86 – $129
Price Chart
About the company
The Estée Lauder Companies Inc. is a global entity dedicated to the development, marketing, and sale of a diverse range of premium beauty and personal care items worldwide. Its extensive product catalog encompasses numerous offerings across four primary categories.
- CEO
- Stephane de la Faverie
- IPO
- 1995
- Employees
- 41,800
- HQ
- New York City, NY, US
AI snapshot
Six angles, distilled from the data.
The stock is in a constructive recovery regime, trading well above its 200-day moving average of 91.35 and 50-day average of 100.92. It sits near the upper end of its 52-week range, with the long-term trend still intact after a sharp rebound from the mid-60s low.
Street sentiment is supportive, with a Buy consensus and a $109.38 median target versus a $112.88 share price. Recent calls have trended higher, including target raises to $129, $125, $124, and $120, even as most firms kept their existing ratings unchanged.
The earnings setup remains favorable after eight straight EPS beats, including a 38.5% surprise last quarter. Next-year EPS is modeled at 3.18 versus 1.03 TTM, so shareholders should watch whether margin recovery and demand can keep that step-up on track.
Recent insider activity leans clearly negative, led by heavy discretionary selling from the CEO and multiple directors. A few M-Exempt transactions reflect award-related activity, but the dominant signal is net selling rather than insider accumulation.
Profitability is solid but not yet fully normalized, with a 76.0% gross margin, 11.0% operating margin, and 2.4% net margin. Revenue grew 6.7% year over year, while free cash flow reached $2.23 billion, giving the company room to fund operations and investment.
EL still commands premium-brand economics versus many consumer staples peers, but the valuation is rich at 51.07 times earnings. The setup favors investors who believe its margin recovery and innovation pipeline can justify that multiple.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $40.52B
- P/E
- 110.78
- Fwd P/E
- 32.56
- PEG
- 0.22
- P/S
- 2.68
- P/B
- 10.17
- EV/EBITDA
- 25.09
- Div Yield
- 1.24%
- Gross Margin
- 76.04%
- Op Margin
- 11.95%
- Net Margin
- 2.41%
- ROE
- 9.28%
- ROIC
- 6.11%
Latest fiscal year · YoY change
- Revenue
- $15.05B+5.0%
- Gross Profit
- $11.36B+7.2%
- Op Income
- $1.68B
- Net Income
- $182.00M+116.1%
- EPS
- $0.50+115.9%
- OCF Growth
- +39.4%
- FCF Growth
- +96.4%
- 52W High
- $121.64
- 52W Low
- $66.22
- 50D MA
- $101.39
- 200D MA
- $91.30
- Beta
- 1.23
- RSI (14)
- 62
- Avg Volume
- 3.53M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Estée Lauder reported a strong first quarter with 6% organic sales growth, sharp margin expansion, and a raised full-year outlook, reinforcing management’s view that Beauty Reimagined is gaining traction.· November 2, 2026
- Organic net sales rose 6% in the quarter; reported sales increased 7%.
- Gross margin expanded 240 bps to 75.7%, operating margin expanded 480 bps to 12.1%, and diluted EPS increased 125% to $0.72.
- Management raised fiscal 2027 guidance for organic sales, operating margin, EPS, and operating cash flow.
- Fragrance led the quarter with 20% organic sales growth; China, Asia Pacific, and Travel Retail were key contributors.
- Management said innovation was strong in the first half and that the back half will lap tougher comparisons, especially in Travel Retail.
First-quarter reported sales increased 7% and organic sales rose 6%. Gross margin was 75.7% versus 73.3% last year, up 240 basis points. Operating margin was 12.1% versus 7.3% last year, up 480 basis points. Diluted EPS was $0.72 versus $0.32 last year, up 125%. Cash flow used for operating activities was $166 million versus $340 million last year, and free cash flow was a use of $235 million versus a use of $436 million. For fiscal 2027, the company raised organic sales growth guidance to 4% to 5.5% from 3% to 5%, operating margin to 12.9% to 13.7% from 12.7% to 13.5%, diluted EPS to $3.20 to $3.45 from $3.10 to $3.35, and net cash flow from operating activities to $1.4 billion to $1.5 billion from $1.3 billion to $1.4 billion.
Stephane de la Faverie framed the quarter as evidence that the recovery is becoming durable and that the company is moving beyond restoring growth toward sustained profitable growth. He emphasized that Beauty Reimagined is broadening performance across categories, regions, and channels, with stronger consumer-facing investment and a more agile operating model. His tone was confident and constructive, especially around fragrance, China, Travel Retail, and online momentum.
Akhil Shrivastava highlighted the margin and cash improvements, citing gross margin of 75.7% and operating margin of 12.1%, both up significantly year over year. He said the gains came from pricing, procurement savings, manufacturing efficiencies, sales leverage, and disciplined cost management, while consumer-facing investment still rose 8% and nonconsumer-facing expenses fell 1%. He also noted improved cash productivity, with operating cash use down to $166 million and capex at $69 million, and said the vast majority of PRGP benefits are still expected by the end of fiscal 2027.
Analysts pressed on whether the stronger Q1 implies a mid-single-digit growth rate for the rest of the year, and management said first-half innovation and Travel Retail comparisons make the back half less strong, though retail momentum remains solid. Questions also focused on One ELC and what it unlocks; management described it as a new operating model aimed at efficiency, agility, and reduced duplication rather than a one-time restructuring event. On margins, management said the full-year guide already reflects some commodity and freight pressure, while on China and the U.S. they said share gains are continuing and that volume gains are increasingly turning into value gains in some brands.
The call showed broad-based momentum: growth accelerated in every region, fragrance and China were particularly strong, and management said retail trends remain positive even as the year progresses. Higher guidance, stronger margins, and improved cash flow suggest the business is translating Beauty Reimagined into measurable financial progress.
Management acknowledged tougher second-half comparisons, especially in Travel Retail, and said innovation contributions will soften later in the year. They also flagged ongoing geopolitical and macro uncertainty, including Middle East-related disruption and some challenges in EUKEM, plus brand-specific issues such as Aveda supply chain logistics and the need to keep improving volume and value share in the U.S. and some other markets.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.5%
- Shares Outstanding
- 362.33M
- Float Shares
- 360.59M
of shares held by institutions
891 13F filers
Buy/sell ratio 0.23. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for EL, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Jonathan JacksonHouse · IL01 | Buy | Sep 28, 26 | Filing → |
| John BoozmanSenate · AR | Buy | Jul 2, 26 | Filing → |
| John BoozmanSenate · AR | Buy | Jul 2, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Aug 5, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 8, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 1, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Apr 9, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Sell | Sep 30, 25 | Filing → |
| Daniel Milton NewhouseHouse · WA04 | Sell | Apr 11, 25 | Filing → |
| Sheldon WhitehouseSenate · RI | Sell | Apr 29, 25 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 5, 25 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Mar 4, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Feb 12, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 27.95M | ▲ 1.04M |
| Bank Of America Corp | 21.25M | ▲ 7.41M |
| Blackrock, Inc. | 20.83M | ▲ 2.28M |
| Vanguard Capital Management LLC | 16.16M | ▲ 82.54K |
| Vanguard Portfolio Management LLC | 12.38M | ▲ 237.49K |
| State Street Corp | 11.54M | ▼ 250.69K |
| Fmr LLC | 10.65M | ▼ 7.47M |
| Eagle Capital Management LLC | 9.01M | ▲ 1.08M |
| Geode Capital Management, LLC | 6.75M | ▲ 91.20K |
| Invesco Ltd. | 5.86M | ▲ 649.56K |
| Bank Of New York Mellon Corp | 5.20M | ▼ 622.56K |
| Independent Franchise Partners Llp | 4.94M | ▼ 1.69M |
Held by 1,901 ETFs
Biggest fund positions in EL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 9, 26 | FRIBOURG PAUL J | sell | 2,406 |
| Nov 9, 26 | de la Faverie Stephane | sell | 9,100 |
| Nov 9, 26 | La Lande Rashida | other | 5,564 |
| Nov 9, 26 | La Lande Rashida | other | 5,564 |
| Nov 9, 26 | La Lande Rashida | sell | 5,564 |
| Nov 9, 26 | La Lande Rashida | sell | 3,315 |
| Nov 5, 26 | FRIBOURG PAUL J | sell | 5,808 |
| Nov 5, 26 | FRIBOURG PAUL J | sell | 2,941 |
| Nov 5, 26 | FRIBOURG PAUL J | sell | 2,742 |
| Nov 5, 26 | FRIBOURG PAUL J | sell | 5,667 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EL coverage
Recent articles, reports, and earnings notes.

Estée Lauder Companies (EL): Recovery Gains, Balance-Sheet Risk Remains
Estée Lauder is showing a credible operational recovery, with organic sales growth, margin expansion, and raised guidance. But leverage, thin net margins, and a premium valuation keep the stock in Hold territory.

The Estée Lauder Companies Inc. (EL) slips after deep earnings beat
The Estée Lauder Companies Inc. (EL) beat EPS and revenue estimates, lifted guidance, and posted broad-based organic growth, yet the stock still slipped. This deep dive weighs margin expansion, fragrance-led momentum, China recovery, and cash flow improvement against the market’s demand for sustained execution.

The Estée Lauder Companies Inc. (EL) slips on earnings beats
The Estée Lauder Companies Inc. (EL) slips 1.2% even after posting earnings beats, as investors weigh the latest results against broader market sentiment.
Want a deeper read on EL?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Can Estee Lauder's New Skin Science Strategy Fuel Long-Term Growth?
zacks.com · Nov 11
Capri Holdings names Estee Lauder senior executive Justin Boxford new CEO
reuters.com · Nov 11
The Estée Lauder Companies 2026 Annual Meeting of Stockholders to Be Held on November 17, 2026
businesswire.com · Nov 10
Estee Lauder's China Business Is Looking Good. That Helps Its Turnaround.
barrons.com · Nov 10
Investing in Estee Lauder (EL)? Don't Miss Assessing Its International Revenue Trends
zacks.com · Nov 9
22,385 The Estee Lauder Companies Inc. $EL Shares Purchased by Candriam S.C.A.
defenseworld.net · Nov 9
COTY or EL: Which Is the Better Value Stock Right Now?
zacks.com · Nov 6
The Estée Lauder Companies Unveils Mastering Skin Longevity, a Breakthrough Scientific Innovation Platform Advancing the Next Era of Skin Science
businesswire.com · Nov 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 10, 2026 · Live quote · Not investment advice